Sparing effect of hemoglobin F and hemoglobin A2 on the polymerization of hemoglobin S at physiologic ligand saturations.
about
Genetic and biochemical markers of hydroxyurea therapeutic response in sickle cell anemia.Kinetics of increased deformability of deoxygenated sickle cells upon oxygenation.Chronic hyper-hemolysis in sickle cell anemia: association of vascular complications and mortality with less frequent vasoocclusive painIn vivo activation of the human δ-globin gene: the therapeutic potential in β-thalassemic mice.Acute chest syndrome is associated with single nucleotide polymorphism-defined beta globin cluster haplotype in children with sickle cell anaemia.Treating sickle cell disease by targeting HbS polymerizationSickle cell disease in Saudi Arabia: the phenotype in adults with the Arab-Indian haplotype is not benign.Fetal haemoglobin levels and haematological characteristics of compound heterozygotes for haemoglobin S and deletional hereditary persistence of fetal haemoglobin.Identification and characterization of mechanistically distinct inducers of gamma-globin transcriptionModulation of fetal hemoglobin in sickle cell anemia.Recombinant erythroid Kruppel-like factor fused to GATA1 up-regulates delta- and gamma-globin expression in erythroid cellsThe genetics of hemoglobin A2 regulation in sickle cell anemiaBCL11A enhancer haplotypes and fetal hemoglobin in sickle cell anemia.Genetic modifiers of sickle cell diseaseAmelioration of murine sickle cell disease by nonablative conditioning and γ-globin gene-corrected bone marrow cells.Combination erythropoietin-hydroxyurea therapy in sickle cell disease: experience from the National Institutes of Health and a literature reviewGene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the β(A(T87Q))-Globin Gene.Original Research: Stable expression of miR-34a mediates fetal hemoglobin induction in K562 cells.Minireview: Multiomic candidate biomarkers for clinical manifestations of sickle cell severity: Early steps to precision medicineLong-Term Engraftment and Fetal Globin Induction upon BCL11A Gene Editing in Bone-Marrow-Derived CD34+ Hematopoietic Stem and Progenitor Cells.Fetal hemoglobin response to hydroxyurea in Yemeni sickle cell disease patients.Sickle-β(+) thalassemia with splenic calcification and bone marrow infarction: a case report.Skeletal and myocardial microvascular blood flow in hydroxycarbamide-treated patients with sickle cell disease.Carbon monoxide religation kinetics to hemoglobin S polymers following ligand photolysis.Inheritance of the Bantu/Benin haplotype causes less severe hemolytic and oxidative stress in sickle cell anemia patients treated with hydroxycarbamide.Fetal hemoglobin in sickle cell anemia: genetic determinants of response to hydroxyureaSickle Cell Disease
P2860
Q31141526-2317A0EB-1315-4953-83E6-CB7FA7941B1FQ33193295-1F6F62C5-3F01-473F-AC29-43DE95952C8AQ33332124-E249D9F8-ACD9-4B07-B7A8-A6431B5A7F29Q33558177-C9BF07D0-7DA0-4F80-B9EE-A3D2B1A9A142Q33631906-21AAA911-6B4D-4961-938E-AC800931E1E3Q33707352-325DBECF-CAE0-402F-AE2B-0E2B549A79B5Q33888761-8AF8CBFA-1AE9-4A9D-95A8-9FBB165629CEQ34053823-A308C226-2CFA-463F-A4B0-80070FB0CC53Q34313801-5B7AD6AF-729E-4946-B80E-5E4E69B67335Q34324076-E9ADF0D9-29E4-4D34-B4E1-8FF4C83A3411Q34707219-47B4CCB5-861C-404F-A7FC-BCECBA11C539Q34981612-F3A369C1-8163-4549-891A-5207D39FCC09Q35124793-1251F4A9-0870-4CC4-A30B-F4FC3E1FA94CQ36035471-5BD5180E-9932-4040-92DB-8DD6585C7655Q36341652-766B4DD9-B96A-4FC3-A48D-10845633C055Q36467377-F630F2E0-0EEB-4729-A224-0D8F7332586AQ36654528-B5B8A031-EF04-4C7B-803D-98DFA65EB95DQ37107187-DA956B8C-E857-4110-B057-B0B2B69608F7Q37107194-F427E618-197A-494E-8959-E4CC92E36DCDQ37717887-9F70204E-B66F-49C4-A93C-B4D7A6D18D4EQ39196524-2EE91BC6-78E8-4A89-9DBB-DE59C3FDBAD2Q41998769-2D4D719F-2247-431C-8D68-E4129868B6BFQ42514544-87DDCC1B-0C27-425E-A2B6-CBD1C58B2E56Q46264888-B86245DD-3BE5-4442-BCFA-4F3C2B4F9C6EQ46582473-84037B41-4078-4BEE-82CC-C6C28ED6EABEQ57318858-33EC9B65-9A44-4468-997C-9D8D99EEF15CQ57629590-57CBA004-910C-48D5-A1CD-1D824D27C717
P2860
Sparing effect of hemoglobin F and hemoglobin A2 on the polymerization of hemoglobin S at physiologic ligand saturations.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Sparing effect of hemoglobin F ...... hysiologic ligand saturations.
@ast
Sparing effect of hemoglobin F ...... hysiologic ligand saturations.
@en
type
label
Sparing effect of hemoglobin F ...... hysiologic ligand saturations.
@ast
Sparing effect of hemoglobin F ...... hysiologic ligand saturations.
@en
prefLabel
Sparing effect of hemoglobin F ...... hysiologic ligand saturations.
@ast
Sparing effect of hemoglobin F ...... hysiologic ligand saturations.
@en
P2093
P2860
P356
P1476
Sparing effect of hemoglobin F ...... hysiologic ligand saturations.
@en
P2093
P2860
P304
P356
10.1073/PNAS.90.11.5039
P407
P577
1993-06-01T00:00:00Z